Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe - EBR:KIN - BE0974274061 - Common Stock

31.725 EUR
+0.03 (+0.08%)
Last: 9/26/2025, 12:26:19 PM
Fundamental Rating

4

Overall KIN gets a fundamental rating of 4 out of 10. We evaluated KIN against 44 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. KIN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year KIN was profitable.
KIN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.54%, KIN is in the better half of the industry, outperforming 70.45% of the companies in the same industry.
The Return On Equity of KIN (23.61%) is better than 84.09% of its industry peers.
KIN has a Return On Invested Capital of 8.28%. This is in the better half of the industry: KIN outperforms 77.27% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KIN is below the industry average of 9.22%.
The 3 year average ROIC (6.76%) for KIN is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

KIN's Profit Margin of 7.98% is fine compared to the rest of the industry. KIN outperforms 72.73% of its industry peers.
KIN's Profit Margin has declined in the last couple of years.
KIN has a better Operating Margin (15.19%) than 86.36% of its industry peers.
KIN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 24.54%, KIN is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of KIN has declined.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, KIN has about the same amount of shares outstanding.
Compared to 5 years ago, KIN has more shares outstanding
Compared to 1 year ago, KIN has an improved debt to assets ratio.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

KIN has an Altman-Z score of 1.58. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
KIN's Altman-Z score of 1.58 is fine compared to the rest of the industry. KIN outperforms 65.91% of its industry peers.
KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.38, KIN is in line with its industry, outperforming 54.55% of the companies in the same industry.
A Debt/Equity ratio of 2.87 is on the high side and indicates that KIN has dependencies on debt financing.
KIN has a Debt to Equity ratio of 2.87. This is in the lower half of the industry: KIN underperforms 70.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.58
ROIC/WACC1.58
WACC5.24%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
KIN has a Current ratio of 0.47. This is amonst the worse of the industry: KIN underperforms 81.82% of its industry peers.
A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.44, KIN is doing worse than 84.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
The Earnings Per Share has been decreasing by -5.80% on average over the past years.
The Revenue has been growing slightly by 5.38% in the past year.
KIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.95% yearly.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

KIN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.11% yearly.
KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y37.47%
EPS Next 2Y27.44%
EPS Next 3Y21.34%
EPS Next 5Y15.11%
Revenue Next Year4.68%
Revenue Next 2Y5.5%
Revenue Next 3Y5.08%
Revenue Next 5Y4.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

KIN is valuated rather expensively with a Price/Earnings ratio of 18.55.
Based on the Price/Earnings ratio, KIN is valued cheaper than 86.36% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.06. KIN is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 11.65, the valuation of KIN can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 86.36% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.64. KIN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.55
Fwd PE 11.65
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as KIN.
84.09% of the companies in the same industry are more expensive than KIN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.65
EV/EBITDA 8.78
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KIN's earnings are expected to grow with 21.34% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y27.44%
EPS Next 3Y21.34%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.19%, KIN has a reasonable but not impressive dividend return.
KIN's Dividend Yield is a higher than the industry average which is at 2.16.
With a Dividend Yield of 1.19, KIN pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.19%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

KIN pays out 31.09% of its income as dividend. This is a sustainable payout ratio.
DP31.09%
EPS Next 2Y27.44%
EPS Next 3Y21.34%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (9/26/2025, 12:26:19 PM)

31.725

+0.03 (+0.08%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21 2025-08-21
Earnings (Next)N/A N/A
Inst Owners15.64%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap868.31M
Analysts86
Price Target49.47 (55.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.19%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.34%
PT rev (3m)-2.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-2.16%
Valuation
Industry RankSector Rank
PE 18.55
Fwd PE 11.65
P/S 1.46
P/FCF 6.65
P/OCF 5
P/B 4.33
P/tB 38.74
EV/EBITDA 8.78
EPS(TTM)1.71
EY5.39%
EPS(NY)2.72
Fwd EY8.58%
FCF(TTM)4.77
FCFY15.04%
OCF(TTM)6.34
OCFY19.98%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.58
F-Score8
WACC5.24%
ROIC/WACC1.58
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y37.47%
EPS Next 2Y27.44%
EPS Next 3Y21.34%
EPS Next 5Y15.11%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year4.68%
Revenue Next 2Y5.5%
Revenue Next 3Y5.08%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year112.63%
EBIT Next 3Y32.23%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%